|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash | |||||||
| Securities | |||||||
| Trade receivables | |||||||
| Tax receivables | |||||||
| Other receivables | |||||||
| Inventories | |||||||
| Restricted cash | |||||||
| Deposits, prepaid and other | |||||||
| Assets held for sale | |||||||
| Total current assets | |||||||
| Non-current Assets | |||||||
| Securities | |||||||
| Equity method investments | |||||||
| Real estate for sale | |||||||
| Investment property | |||||||
| Property, plant and equipment | |||||||
| Interests in resource properties | |||||||
| Deferred income tax assets | |||||||
| Other non-current assets | |||||||
| Total non-current assets | |||||||
| Total assets | |||||||
| LIABILITIES AND EQUITY | |||||||
| Current Liabilities | |||||||
| Account payables and accrued expenses | |||||||
| Income tax liabilities | |||||||
| Dividend payable | |||||||
| Liabilities relating to assets held for sale | |||||||
| Total current liabilities | |||||||
| Non-current Liabilities | |||||||
| Bonds payable | |||||||
| Loan payable | |||||||
| Deferred income tax liabilities | |||||||
| Other non-current liabilities | |||||||
| Total non-current liabilities | |||||||
| Total liabilities | |||||||
| Equity | |||||||
| Capital stock, fully paid (Common shares 300,000,000 and preference shares 150,000,000 authorized; common shares 14,822,251 issued and outstanding) | |||||||
| Additional paid-in capital | |||||||
| Treasury stock | |||||||
| Contributed surplus | |||||||
| Deficit | |||||||
| Accumulated other comprehensive income | |||||||
| Shareholders' equity | |||||||
| Non-controlling interests | |||||||
| Total equity | |||||||
| Total liabilities and equity | |||||||
Loading...